Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sernova Corp (SVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3305
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from immune system. The company’s product portfolio addresses metabolic diseases such as insulin dependent diabetes and thyroid disease; and blood disorders such as hemophilia A; and other neurological ailments. Sernova is headquartered in London, Ontario, Canada.

Sernova Corp (SVA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sernova Corp, Medical Devices Deals, 2012 to YTD 2018 9
Sernova Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sernova Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sernova Enters into Research Agreement with Massachusetts General Hospital 11
Sernova And Medicyte Enter Into Co-Development Agreement For Pouch/Upcyte Combination Product 12
Licensing Agreements 13
Sernova Enters into Licensing Agreement with University Health Network 13
Equity Offering 14
Sernova to Raise USD2.5 Million in Private Placement of Shares 14
Sernova Raises USD1.7 Million in Second and Final Tranche of Private Placement of Units 15
Sernova Raises USD1.6 Million in First Tranche of Private Placement of Units 17
Sernova Raises USD1.3 Million Private Placement of Shares 18
Sernova Completes Private Placement Of Units For US$2 Million 19
Sernova Completes Second Tranche Of Private Placement Of Units For US$0.14 Million 20
Sernova Corp – Key Competitors 21
Sernova Corp – Key Employees 22
Sernova Corp – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Government and Public Interest 24
Jun 05, 2017: Sernova Provides Company Outlook on Corporate and Clinical Developments 24
Other Significant Developments 25
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Sernova Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Sernova Corp, Medical Devices Deals, 2012 to YTD 2018 9
Sernova Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sernova Enters into Research Agreement with Massachusetts General Hospital 11
Sernova And Medicyte Enter Into Co-Development Agreement For Pouch/Upcyte Combination Product 12
Sernova Enters into Licensing Agreement with University Health Network 13
Sernova to Raise USD2.5 Million in Private Placement of Shares 14
Sernova Raises USD1.7 Million in Second and Final Tranche of Private Placement of Units 15
Sernova Raises USD1.6 Million in First Tranche of Private Placement of Units 17
Sernova Raises USD1.3 Million Private Placement of Shares 18
Sernova Completes Private Placement Of Units For US$2 Million 19
Sernova Completes Second Tranche Of Private Placement Of Units For US$0.14 Million 20
Sernova Corp, Key Competitors 21
Sernova Corp, Key Employees 22

List of Figures
Sernova Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sernova Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nestle (Malaysia) Bhd:企業の戦略・SWOT・財務情報
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Laboratorio Reig Jofre SA (RJF):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and consumer healthcar …
  • SThree Plc (STHR):企業の財務・戦略的SWOT分析
    Summary SThree Plc (Sthree) is a staffing company that offers permanent and contract staffing business. The company operates through its sectors such as information and communications technology (ICT), energy, engineering, life sciences, banking and finance. Its business brands such as Computer Futu …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • ExpressJet Airlines, Inc:企業の戦略・SWOT・財務情報
    ExpressJet Airlines, Inc - Strategy, SWOT and Corporate Finance Report Summary ExpressJet Airlines, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Med BioGene Inc (MBI):企業の財務・戦略的SWOT分析
    Med BioGene Inc (MBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Roadrunner Transportation Systems Inc.:企業のM&A・事業提携・投資動向
    Roadrunner Transportation Systems Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roadrunner Transportation Systems Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • ALTANA AG:戦略・SWOT・企業財務分析
    ALTANA AG - Strategy, SWOT and Corporate Finance Report Summary ALTANA AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • JW Pharmaceutical Corp (001060):企業の財務・戦略的SWOT分析
    Summary JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agent …
  • Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that offers novel therapeutics to treat diseases of the back of the eye for age-related macular degeneration. The company’s products include Zimura, an anti-complemente is a central component of the complement cascade that is suppos …
  • SK Kaken Co Ltd (4628):企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Admedus Ltd (AHZ):製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …
  • Otter Tail Corp:企業の発電所・SWOT分析2018
    Otter Tail Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Japan Airport Terminal Co Ltd:企業の戦略・SWOT・財務分析
    Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • WPPI Energy Inc:企業の戦略的SWOT分析
    WPPI Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Abide Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abide Therapeutics Inc (Abide) is a clinical development stage company that discovers and develops therapeutic potential of serine hydrolases to transform the lives of patients with serious unmet medical needs. The company’s pipeline include ABX-1431, a first-in-class inhibitor of the serine …
  • Imperial Brands Plc:戦略・SWOT・企業財務分析
    Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report Summary Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Deluxe Corporation:企業の戦略・SWOT・財務分析
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dalton Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary Dalton Pharma Services (Dalton) is a contract manufacturing company that offers discovery, development and contract manufacturing services. The company’s product categories include building blocks, coelenterazines, drugs and metabolites, glitazones, gmp APIs, excipients and reagents, heteroc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆